THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug watch: ADZYNMA under microscope for rare TTP patients
Disease control Recruiting nowThis study tracks the safety of a drug called ADZYNMA in 40 people with a rare blood disorder (congenital TTP) in Japan. Doctors will monitor side effects and check if the drug helps prevent or treat TTP episodes over 18 months. Participants receive the drug as part of their norm…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Massive study unlocks secrets of rare blood disease survivors
Knowledge-focused Recruiting nowThis study reviews medical records from over 1,200 people with immune thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood disorder. The goal is to understand long-term health issues like heart disease and how new treatments affect survival. No new treatm…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 06:16 UTC
-
TTP immune secrets: study aims to predict relapses before they happen
Knowledge-focused Recruiting nowThis study looks at specific immune cells in people with thrombotic thrombocytopenic purpura (TTP), a rare blood disorder. Researchers want to understand how these cells change during the disease and after treatment. The goal is to find early warning signs of relapse, so doctors …
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 17, 2026 06:15 UTC